Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Session 16: COVID-19 Vaccines Impact Modelling - Key Issues to know about Modeled Evidence to Inform Prioritization and Delivery

This files gathers all answers to the questions asked during Sessions #16 of the 'Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines' webinar series. This session was entitled 'COVID-19 Vaccines Impact Modelling - Key Issues to know about Modeled Evidence to Inform Prioritization and Delivery' and took place on Wednesday, December 8, 2021

Authors